Cite
[Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone].
MLA
Hirata, S., et al. “[Neoadjuvant Chemotherapy for Esophageal Cancer by Administration of Nedaplatin Alone].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 27, no. 2, Feb. 2000, pp. 221–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10700891&authtype=sso&custid=ns315887.
APA
Hirata, S., Yatsuyanagi, E., Yamazaki, H., Sugimoto, Y., Kosiko, S., Kokubo, T., Atsuta, Y., Sasajima, T., & Miyokawa, N. (2000). [Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 27(2), 221–226.
Chicago
Hirata, S, E Yatsuyanagi, H Yamazaki, Y Sugimoto, S Kosiko, T Kokubo, Y Atsuta, T Sasajima, and N Miyokawa. 2000. “[Neoadjuvant Chemotherapy for Esophageal Cancer by Administration of Nedaplatin Alone].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 27 (2): 221–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10700891&authtype=sso&custid=ns315887.